Multidisciplinary care and cutting-edge research share space at The Neuro

The Montreal Neurological Institute and Hospital (The Neuro) is recognized worldwide for its research and clinical expertise in Parkinson’s disease (PD). PD is a motor neuron disease that is generally associated with old age, but people can also develop it in their thirties and forties. Characteristic symptoms include tremor, rigidity and gait dysfunction, mood and sleep disorders, and cognitive degeneration. About 100,000 Canadians have PD.

Classified as: medicine research, Neuro, Montreal Neurological Institute and Hospital, Edward Fon, Anne-Louise Lafontaine, Lesley Fellows, alain dagher, Louis Collins, Ron Postuma, Abbas Sadikot
Category:
Published on: 1 Apr 2017

Discovery expands our understanding of how we remember sound

The ability to remember sounds, and manipulate them in our minds, is incredibly important to our daily lives — without it we would not be able to understand a sentence, or do simple arithmetic. New research is shedding light on how sound memory works in the brain, and is even demonstrating a means to improve it.

Classified as: Montreal Neurological Institute, Neuroimaging and Neuroinformatics, Neurocognition, Sylvain Baillet, Robert Zatorre, Dr. Robert Zatorre
Published on: 27 Mar 2017

March 26 is Purple Day for Epilepsy, a day to support epilepsy awareness worldwide

The Neuro has been a world leader in epilepsy treatment and research for more than 60 years. Indeed, the “Montreal Procedure” developed by The Neuro’s founder, Dr. Wilder Penfield, and his colleagues has become the standard operating procedure for the surgical treatment of epilepsy. The Neuro was also a pioneering institute in exploiting electroencephalography (EEG) and magnetic resonance imaging (MRI) to study and treat epilepsy.

Classified as: Neuro, epilepsy, mcgill faculty of medicine research, Montreal Neurological Institute and Hospital, neuroscience, Andrea Bernasconi, Eva Andermann, Neda Ladbon-Bernasconi, Boris Bernhardt, Francois Dubeau, Jean Gotman, Jeffrey Hall, Eliane Kobayashi
Category:
Published on: 26 Mar 2017

Deep learning transforming neuroscience research

In an article published in Nature on Feb. 15, 2017, researchers, including principal investigators from the Montreal Neurological Institute’s McConnell Brain Imaging Centre (BIC), used magnetic resonance imaging (MRI) to predict the development of autism in babies.

Classified as: MNI, autism, Neuro, Sylvain Baillet, BIC, neuroimaging, brain imaging centre, deep learning
Published on: 20 Mar 2017

Montreal, Quebec and Vancouver, British Columbia – Working together to accelerate research into neurological diseases, three leading players in Canada’s health sciences sector are joining forces in a unique multi-million dollar partnership to create a novel drug development platform that will help advance new therapeutics for some of the most debilitating conditions such as amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig’s disease, and Parkinson’s disease.

Classified as: drug development, Merck, CDRD, Parkinson's, Guy Rouleau
Published on: 16 Mar 2017

Discovery could be key to treating brain and spinal cord injury

A foray into plant biology led one researcher to discover that a natural molecule can repair axons, the thread-like projections that carry electrical signals between cells. Axonal damage is the major culprit underlying disability in conditions such as spinal cord injury and stroke.

Classified as: Neuro, MNI, stroke, Neurology, spinal cord injury, axon repair, 14-3-3, Fusicoccin-A, Alyson Fournier
Published on: 8 Mar 2017

Research and clinical care complement each other at The Neuro

February 28th was Rare Diseases Day, an opportunity to recognize a class of disease that is often overlooked. In the past five years, the Montreal Neurological Institute and Hospital (The Neuro) has made the study and treatment of rare diseases a major priority, hiring new specialists and support staff and coordinating activity under a new research group.

Classified as: Rare disases, Bernard Brais, genetics, Eric Shoubridge, ataxia, Heidi McBride, Guy Rouleau
Published on: 28 Feb 2017

The BIC hosted a series of Deep Learning workshops organized by Santiago Paiva (Hoge lab) and Dr. Robert Brown (Arnold lab) on January 19th and 26th. 

Classified as: BIC
Category:
Published on: 6 Feb 2017

We are pleased to welcome Dr. Stephan Blinder as the new BIC PET physicist on staff. 
Stephan completed his PhD in Astrophysics (U de Bordeaux I, France) and later shifted his interest towards biomedical imaging research. He worked for 4 years with the MIRG group led by Dr. Anna Celler (U of British Columbia, Vancouver) on SPECT imaging, focusing on 3D and 4D image reconstruction techniques. 

Classified as: BIC
Category:
Published on: 6 Feb 2017

CQDM and Brain Canada join forces again in the funding of two new research projects to address unmet needs in brain research

CQDM and Brain Canada are proud to announce the funding of two new multi-disciplinary and multi-institutional research projects under the second edition of their Focus on Brain strategic initiative. The partners will award a total of $3M to two research teams to develop cutting-edge tools, technologies and platforms designed to accelerate the discovery of new drugs for brain and nervous system disorders.

Classified as: ALS, Parkinson's, Brain Canada, CQDM, Canada Brain Research Fund, Fon, Edward Fon, Ted Fon
Published on: 2 Feb 2017

Project will enhance mental health access for multicultural communities

On Jan. 18, 2017, Bell Let’s Talk announced a donation of $250,000 to McGill University’s Montreal Neurological Institute and Hospital – known as The Neuro – to fund the development of online mental health resources focused on the needs of multicultural communities.

Classified as: Bell Let's Talk, Bell, mental health, Multicultural Mental Health Resource Centre, Guy Rouleau
Published on: 18 Jan 2017

An all-star lineup of experts in the fields of sports and neurology will share a stage on Jan. 27 to discuss concussions, a serious injury that has only recently been getting the attention it deserves.

Classified as: Concussion, sport, brain injury, HEADS UP, alain ptito, Athletics, Angela Genge, Dr. Angela Genge, alain ptito, Guy Rouleau
Published on: 11 Jan 2017

Have you ever met someone who just wasn’t into music? They may have a condition called specific musical anhedonia, which affects three-to-five per cent of the population.

Researchers at the University of Barcelona and the Montreal Neurological Institute and Hospital of McGill University have discovered that people with this condition showed reduced functional connectivity between cortical regions responsible for processing sound and subcortical regions related to reward.

Classified as: specific musical anhedonia, Robert Zatorre, fMRI, neuroscience, University of Barcelona
Published on: 4 Jan 2017

Drug shown to reduce new attacks/symptom progression in some patients

In separate clinical trials, a drug called ocrelizumab has been shown to reduce new attacks in patients with relapsing remitting multiple sclerosis (MS), and new symptom progression in primary progressive MS.

Classified as: MS, ocrelizumab, Amit Bar-Or, Douglas Arnold, Multiple Sclerosis
Published on: 22 Dec 2016

Truly happy to see Ted join our core staff as Manager, Data Resources. Ted has 12+ years experience as a programmer, database administrator and technology generalist in the industry and academia. He will assist in creating a strategy and enabling the tools for short- and long-term data management over all modalities used at our Centre, all in coordination with the developments of the MNI's open-science infrastructure. 
Ted will draw from several years supporting open source, open data, and open science through policy and organizing. 

Classified as: BIC
Category:
Published on: 13 Dec 2016

Pages

Back to top